Single-cell analysis of adult human heart across healthy and cardiovascular disease patients reveals the cellular landscape underlying SARS-CoV-2 invasion of myocardial tissue through ACE2

[1]  J. Lieberman,et al.  Inflammasome activation in infected macrophages drives COVID-19 pathology , 2021, Nature.

[2]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[3]  M. Farzan,et al.  Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.

[4]  Panteleimon G. Takis,et al.  Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study , 2021, The Lancet.

[5]  G. Ippolito,et al.  Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review , 2021, International journal of molecular sciences.

[6]  J. Loscalzo,et al.  COVID-19 and Cardiovascular Disease , 2021, Circulation research.

[7]  M. Schwerzmann,et al.  COVID-19 in Adults With Congenital Heart Disease , 2021, Journal of the American College of Cardiology.

[8]  David S. Fischer,et al.  Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics , 2021, Nature Medicine.

[9]  Shai-hong Zhu,et al.  Emerging Role of Pericytes and Their Secretome in the Heart , 2021, Cells.

[10]  K. Klingel,et al.  Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy , 2021, Circulation.

[11]  M. Caputo,et al.  The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease , 2020, bioRxiv.

[12]  M. Schwerzmann,et al.  Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease , 2020, European heart journal.

[13]  E. Kudryashova,et al.  Opposing activities of IFITM proteins in SARS‐CoV‐2 infection , 2020, The EMBO journal.

[14]  R. Bhandari,et al.  Sex-Specific Platelet Activation Through Protease-Activated Receptors Reverses in Myocardial Infarction , 2020, Arteriosclerosis, thrombosis, and vascular biology.

[15]  J. Kolls,et al.  The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection , 2020, JACC: Basic to Translational Science.

[16]  Jingwei Bian,et al.  Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator , 2020, Acta Pharmaceutica Sinica B.

[17]  D. Zipeto,et al.  ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19 , 2020, Frontiers in Immunology.

[18]  Catherine L. Worth,et al.  Cells of the adult human heart , 2020, Nature.

[19]  Jacques Fellay,et al.  Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.

[20]  P. Kirchhof,et al.  Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.

[21]  Han-bin Lin,et al.  COVID-19 and the Heart , 2020, JACC: Basic to Translational Science.

[22]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[23]  Quanlong Jiang,et al.  Individual variation of the SARS‐CoV‐2 receptor ACE2 gene expression and regulation , 2020, Aging cell.

[24]  Lisa E. Gralinski,et al.  SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract , 2020, Cell.

[25]  M. Pfeffer,et al.  Plasma angiotensin-converting enzyme 2: novel biomarker in heart failure with implications for COVID-19 , 2020, European heart journal.

[26]  J. Knight,et al.  Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019 , 2020, The Journal of infectious diseases.

[27]  I. Ali,et al.  COVID-19: Disease, management, treatment, and social impact , 2020, Science of The Total Environment.

[28]  Ian A. Carroll,et al.  Dynamic Regulation of SARS-Cov-2 Binding and Cell Entry Mechanisms in Remodeled Human Ventricular Myocardium , 2020, JACC: Basic to Translational Science.

[29]  Yan Liu,et al.  Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV , 2020, Nature Communications.

[30]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[31]  Dan Zhang,et al.  Construction of a human cell landscape at single-cell level , 2020, Nature.

[32]  A. Walls,et al.  Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.

[33]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[34]  K. Ardlie,et al.  Transcriptional and Cellular Diversity of the Human Heart , 2020, bioRxiv.

[35]  Shengshou Hu,et al.  Single-cell reconstruction of the adult human heart during heart failure and recovery reveals the cellular landscape underlying cardiac function , 2020, Nature Cell Biology.

[36]  Christopher N. Johnson,et al.  Genetic Mosaicism in Calmodulinopathy. , 2019, Circulation. Genomic and precision medicine.

[37]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[38]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[39]  Steven G. Luke,et al.  Evaluating significance in linear mixed-effects models in R , 2016, Behavior Research Methods.

[40]  José G. Pérez-Silva,et al.  The Degradome database: expanding roles of mammalian proteases in life and disease , 2015, Nucleic Acids Res..

[41]  R. Cooke,et al.  Best practice BioBanking of human heart tissue , 2015, Biophysical Reviews.

[42]  R. Bull,et al.  The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry* , 2015, The Journal of Biological Chemistry.

[43]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[44]  Annik Prat,et al.  The biology and therapeutic targeting of the proprotein convertases , 2012, Nature Reviews Drug Discovery.

[45]  B. Bosch,et al.  Cathepsin L Functionally Cleaves the Severe Acute Respiratory Syndrome Coronavirus Class I Fusion Protein Upstream of Rather than Adjacent to the Fusion Peptide , 2008, Journal of Virology.

[46]  T. Sasazuki,et al.  Modulation of TNF-α-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-α production and facilitates viral entry , 2008, Proceedings of the National Academy of Sciences.

[47]  S. Harrison,et al.  SARS Coronavirus, but Not Human Coronavirus NL63, Utilizes Cathepsin L to Infect ACE2-expressing Cells , 2006, Journal of Biological Chemistry.

[48]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[49]  G. Oudit,et al.  Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS. , 2014, Journal of molecular and cellular cardiology.